Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Nanjing, Jiangsu
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Clinical Trials in Nanjing, Jiangsu
1 recruiting
Nanjing, Jiangsu, China
Showing
1–1
of
1
trials
Recruiting
Phase 3
Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPC
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
The First Affiliated Hospital with Nanjing Medical University
100 enrolled
1 location
NCT05956639
Feedback